Boiron SA - Asset Resilience Ratio

Latest as of December 2023: -0.13%

Boiron SA (BOI) has an Asset Resilience Ratio of -0.13% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check BOI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€-747.00K
≈ $-873.32K USD Cash + Short-term Investments

Total Assets

€590.20 Million
≈ $690.01 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2001–2023)

This chart shows how Boiron SA's Asset Resilience Ratio has changed over time. See BOI equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Boiron SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BOI market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €-747.00K -0.13%
Total Liquid Assets €-747.00K -0.13%

Asset Resilience Insights

  • Limited Liquidity: Boiron SA maintains only -0.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Boiron SA Industry Peers by Asset Resilience Ratio

Compare Boiron SA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 48.48%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
Drug Manufacturers - Specialty & Generic 5.92%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Dermapharm Holding SE
XETRA:DMP
Drug Manufacturers - Specialty & Generic 1.23%
China Animal Husbandry Industry Co Ltd
SHG:600195
Drug Manufacturers - Specialty & Generic 3.81%
Daewoong Pharma
KO:069620
Drug Manufacturers - Specialty & Generic 0.19%
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
Drug Manufacturers - Specialty & Generic 2.09%

Annual Asset Resilience Ratio for Boiron SA (2001–2023)

The table below shows the annual Asset Resilience Ratio data for Boiron SA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -0.13% €-747.00K
≈ $-873.32K
€590.20 Million
≈ $690.01 Million
-0.09pp
2022-12-31 -0.03% €-260.00K
≈ $-303.97K
€789.49 Million
≈ $923.00 Million
+0.02pp
2021-12-31 -0.05% €-398.00K
≈ $-465.30K
€770.70 Million
≈ $901.03 Million
0.00pp
2020-12-31 -0.05% €-397.00K
≈ $-464.13K
€781.82 Million
≈ $914.03 Million
+0.00pp
2019-12-31 -0.05% €-411.00K
≈ $-480.50K
€764.28 Million
≈ $893.53 Million
-0.06pp
2015-12-31 0.01% €41.00K
≈ $47.93K
€695.45 Million
≈ $813.05 Million
+0.49pp
2012-12-31 -0.48% €-2.79 Million
≈ $-3.26 Million
€579.28 Million
≈ $677.24 Million
-0.92pp
2001-12-31 0.44% €905.00K
≈ $1.06 Million
€205.86 Million
≈ $240.67 Million
--
pp = percentage points

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic
Market Cap
$562.26 Million
€480.94 Million EUR
Market Cap Rank
#12647 Global
#193 in France
Share Price
€27.70
Change (1 day)
-0.36%
52-Week Range
€20.90 - €31.70
All Time High
€59.48
About

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more